Cyclana Bio Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $6.71M

  • Investors
  • 6

Cyclana Bio General Information

Description

Developer of a therapeutic discovery platform intended to uncover disease mechanisms in women's health. The company's platform utilizes advanced tissue and matrix biology techniques, including the analysis of collected human menstrual fluid, to build first-of-a-kind physiological assays of the diseased tissue niche and better stratify complex health conditions, enabling therapeutic researchers to pinpoint the precise disease-driving biological targets necessary for developing novel and effective treatment options for women suffering from severely underserved conditions like endometriosis.

Contact Information

Formerly Known As
Cycle Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • LiveLabs, Meditrina Building
  • Babraham Research Campus, Babraham
  • Cambridge CB22 3AT
  • England, United Kingdom
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • LiveLabs, Meditrina Building
  • Babraham Research Campus, Babraham
  • Cambridge CB22 3AT
  • England, United Kingdom

Cyclana Bio Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cyclana Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 20-Oct-2025 $6.71M Completed Startup
1. Accelerator/Incubator 12-Jun-2025 Completed Startup
To view Cyclana Bio’s complete valuation and funding history, request access »

Cyclana Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Pre-Seed
To view Cyclana Bio’s complete cap table history, request access »

Cyclana Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cyclana Bio Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cocoa Ventures Venture Capital Minority
Eka Ventures Venture Capital Minority
Lavender Ventures Venture Capital Minority
NFX Venture Capital Minority
Wilbe Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Cyclana Bio FAQs

  • When was Cyclana Bio founded?

    Cyclana Bio was founded in 2024.

  • Where is Cyclana Bio headquartered?

    Cyclana Bio is headquartered in Cambridge, United Kingdom.

  • What is the size of Cyclana Bio?

    Cyclana Bio has 4 total employees.

  • What industry is Cyclana Bio in?

    Cyclana Bio’s primary industry is Discovery Tools (Healthcare).

  • Is Cyclana Bio a private or public company?

    Cyclana Bio is a Private company.

  • What is the current valuation of Cyclana Bio?

    The current valuation of Cyclana Bio is .

  • What is Cyclana Bio’s current revenue?

    The current revenue for Cyclana Bio is .

  • How much funding has Cyclana Bio raised over time?

    Cyclana Bio has raised $6.72M.

  • Who are Cyclana Bio’s investors?

    Cocoa Ventures, Eka Ventures, Lavender Ventures, NFX, and Wilbe Capital are 5 of 6 investors who have invested in Cyclana Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process